Corazon Frias Selected Research

talabostat

1/2022

B-nor-methylene Colchicinoid PT-100 Selectively Induces Apoptosis in Multidrug-Resistant Human Cancer Cells via an Intrinsic Pathway in a Caspase-Independent Manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Corazon Frias Research Topics

Disease

6	Neoplasms (Cancer) 01/2022 - 09/2010
5	Lymphoma (Lymphomas) 01/2022 - 12/2009
3	Leukemia 11/2021 - 01/2015
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 10/2005
2	Adenocarcinoma 01/2022 - 01/2015
1	Melanoma (Melanoma, Malignant) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Carcinoma (Carcinomatosis) 01/2015
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2005

Drug/Important Bio-Agent (IBA)

3	Vincristine (Oncovin)FDA LinkGeneric 09/2021 - 01/2015
2	MetalsIBA 09/2021 - 04/2018
1	talabostatIBA 01/2022
1	CaspasesIBA 01/2022
1	GoldIBA 11/2021
1	DNA (Deoxyribonucleic Acid)IBA 09/2021
1	Pharmaceutical PreparationsIBA 09/2021
1	LigandsIBA 09/2021
1	Daunorubicin (Cerubidine)FDA LinkGeneric 04/2018
1	NucleosidesIBA 06/2015
1	RutheniumIBA 09/2010
1	Caspase 9IBA 12/2009
1	demethylxanthohumolIBA 10/2005